Abdominal Abscess: Clinical Trials

3 trials for Abdominal Abscess, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Abdominal Abscess: new trials by email Literature Review of Abdominal Abscess trials Research Report on Abdominal Abscess

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Laparoscopic Management of Periappendicular Abscess
Laparoscopic appendectomy, Conservative management with percutaneous drainage - Appendicitis, Abdominal Abscess
Phase 2CompletedHelsinki University Central Hospital602011-01-012014-09-23
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
Imipenem/cilastatin, Doripenem - Pneumonia, Ventilator-Associated, Pneumonia, Bacterial
Phase 2CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.1462007-10-012019-03-19
Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
Alteplase, saline - Abdominal Abscess, Pelvic Abscess
Phase 2CompletedKaiser Permanente202006-02-012015-02-26

Narrower conditions

Appendicitis (1)  ·  Bacterial Infections (1)  ·  Fever (1)  ·  Ileus (1)  ·  Pneumonia (1)  ·  Pneumonia, Bacterial (1)  ·  Pneumonia, Ventilator-Associated (1)

Broader conditions

Abscess (3)  ·  Infections (3)  ·  Suppuration (3)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Bacterial Infections and Mycoses (1)  ·  Body Temperature Changes (1)  ·  Cecal Diseases (1)  ·  Cross Infection (1)  ·  Disease Attributes (1)  ·  Gastroenteritis (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Iatrogenic Disease (1)  ·  Intestinal Obstruction (1)

Interventions

Cilastatin, Imipenem Drug Combination (1)  ·  Conservative Treatment (1)  ·  Doripenem (1)  ·  Sodium Chloride (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

Helsinki University Central Hospital (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Kaiser Permanente (1)

Countries

Finland (1)  ·  United States (1)

Top investigators

Hyo-Chun Yoon, MD, PhD (1)  ·  Panu Mentula, M.D. Ph.D. (1)